1. X
  2. OncLive.com
Log inSign up
OncLive.com
119.3K posts
Image
user avatar
OncLive.com
@OncLive
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.
New Jersey, USA
onclive.com
Joined May 2009
2,007
Following
50K
Followers
RepliesRepliesMediaMedia

New to X?

Sign up now to get your own personalized timeline!

Create account

By signing up, you agree to the Terms of Service and Privacy Policy, including Cookie Use.

Terms·Privacy·Cookies·Accessibility·Ads Info·© 2026 X Corp.
Don't miss what's happening
People on X are the first to know.
Log inSign up
  • user avatar
    OncLive.com
    @OncLive
    Jan 20, 2025
    AVA6000 Elicits Clinically Meaningful Tumor Shrinkage in Salivary Gland Cancer #Oncology #MedTwitter
    onclive.com
    AVA6000 Elicits Clinically Meaningful Tumor Shrinkage in Salivary Gland Cancer | OncLive
    Preliminary data show that AVA6000 led to robust and clinically meaningful tumor shrinkage in patients with salivary gland cancer.
    20K020K
  • user avatar
    OncLive.com
    @OncLive
    Sep 1, 2020
    BREAKING: #FDA Approves Oral Azacitidine for Acute Myeloid Leukemia @US_FDA #leusm ow.ly/gxJW50Bf0jg
    Image
  • user avatar
    OncLive.com
    @OncLive
    May 30, 2025
    Big smiles during this celebratory night at Giants of Cancer Care. A heartfelt congratulations to @szusmani! #GiantsCC25
    Image
    6.4K06.4K
  • user avatar
    OncLive.com
    @OncLive
    Feb 14, 2022
    The Magnificence of the Possible: Toni K. Choueiri Gets Giants of Cancer Care Award in GU Cancer @DrChoueiri @DanaFarber @harvardmed #oncology #MedTwitter ow.ly/Yhbw50HUNuu
  • user avatar
    OncLive.com
    @OncLive
    May 31, 2024
    #GiantsCC24 inductee in Leukemia, congratulations, @garciamanero! #leusm
    Image
    13K013K
  • user avatar
    OncLive.com
    @OncLive
    Aug 17, 2018
    BREAKING: FDA Approves Nivolumab for Small Cell Lung Cancer onclive.com/web-exclusives…
  • user avatar
    OncLive.com
    @OncLive
    Jun 2, 2023
    We congratulate @CharlesSwanton of @TheCrick and @uclcancer our 2023 Giant of Cancer Care® winner in Translational Science! #GiantsCC23
    Image
    8.5K08.5K
  • user avatar
    OncLive.com
    @OncLive
    Nov 27, 2022
    Autologous tumor lysate-loaded dendritic cell vaccination used in combination with standard-of-care treatment extended overall survival for patients with newly diagnosed glioblastoma as well as those with recurrent disease. #btsm #oncology
    DCVax-L Improves Survival in Glioblastoma | OncLive
    onclive.com
    DCVax-L Improves Survival in Glioblastoma | OncLive
    Autologous tumor lysate-loaded dendritic cell vaccination used in combination with standard-of-care treatment extended overall survival for patients with newly diagnosed glioblastoma as well as those...
  • user avatar
    OncLive.com
    @OncLive
    Mar 30, 2021
    On the Move: @NarjustDumaMD Named Associate Director of the Cancer Equity Program at @DanaFarber #healthequity #cancerequity ow.ly/ZfkJ50EcJZa
  • user avatar
    OncLive.com
    @OncLive
    Feb 8, 2025
    Treatment with the investigative AVA6000 peptide drug conjugate consisting of doxorubicin led to clinically meaningful tumor shrinkage in patients with FAP–positive salivary gland cancer. #hncsm #oncology #MedTwitter hubs.li/Q035jRx50
    Image
    12K012K
  • user avatar
    OncLive.com
    @OncLive
    Jun 2, 2023
    Congrats to @EileenMOReilly of @MSKCancerCenter, our 2023 Giant of Cancer Care in Gastrointestinal Cancer! #GiantsCC23
    Image
    6K06K
  • user avatar
    OncLive.com
    @OncLive
    Apr 5, 2024
    BREAKING: @US_FDA Grants Accelerated Approval to Trastuzumab Deruxtecan for Unresectable or Metastatic HER2+ Solid Tumors #oncology #medtwitter onclive.com/view/fda-grant…
    Image
    11K011K
  • user avatar
    OncLive.com
    @OncLive
    Feb 7, 2025
    Preliminary data show that AVA6000 led to robust and clinically meaningful tumor shrinkage in patients with salivary gland cancer. #hncsm #oncology #MedTwitter
    AVA6000 Elicits Clinically Meaningful Tumor Shrinkage in Salivary Gland Cancer | OncLive
    onclive.com
    AVA6000 Elicits Clinically Meaningful Tumor Shrinkage in Salivary Gland Cancer | OncLive
    Preliminary data show that AVA6000 led to robust and clinically meaningful tumor shrinkage in patients with salivary gland cancer.
    7.2K07.2K
  • user avatar
    OncLive.com
    @OncLive
    Jan 27, 2023
    BREAKING: @US_FDA Approves Pirtobrutinib for Relapsed or Refractory Mantle Cell Lymphoma #lymsm #oncology ow.ly/96V750MCqRx
    Image
    14K014K
Advertisement
Advertisement